Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
CNY 10.94
(0.46%)
CNY 10.94
(0.46%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.05 CNY | 125.81% |
| 2022 | -0.21 CNY | -61.54% |
| 2021 | -0.13 CNY | 65.79% |
| 2020 | -0.38 CNY | -337.5% |
| 2019 | 0.16 CNY | -54.29% |
| 2018 | 0.35 CNY | -22.22% |
| 2017 | 0.45 CNY | -2.17% |
| 2016 | 0.46 CNY | -8.0% |
| 2015 | 0.50 CNY | 108.33% |
| 2014 | 0.24 CNY | -38.46% |
| 2013 | 0.39 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.01 CNY | -68.92% |
| 2024 Q2 | 0.00 CNY | -91.3% |
| 2024 Q3 | -0.03 CNY | -3975.0% |
| 2023 Q1 | 0.02 CNY | 108.27% |
| 2023 Q3 | 0.01 CNY | 733.33% |
| 2023 Q2 | -0.00 CNY | -106.59% |
| 2023 Q4 | 0.03 CNY | 289.47% |
| 2023 FY | - CNY | 125.81% |
| 2022 FY | - CNY | -61.54% |
| 2022 Q4 | -0.22 CNY | -6045.95% |
| 2022 Q3 | 0.00 CNY | 384.62% |
| 2022 Q2 | -0.00 CNY | -117.81% |
| 2022 Q1 | 0.01 CNY | 103.65% |
| 2021 Q3 | 0.01 CNY | -67.63% |
| 2021 Q4 | -0.20 CNY | -1581.48% |
| 2021 Q1 | 0.01 CNY | 104.5% |
| 2021 FY | - CNY | 65.79% |
| 2021 Q2 | 0.04 CNY | 256.41% |
| 2020 Q4 | -0.26 CNY | -447.37% |
| 2020 Q3 | -0.05 CNY | -47.98% |
| 2020 Q2 | -0.03 CNY | 25.35% |
| 2020 Q1 | -0.04 CNY | -188.11% |
| 2020 FY | - CNY | -337.5% |
| 2019 FY | - CNY | -54.29% |
| 2019 Q4 | 0.05 CNY | 750.67% |
| 2019 Q3 | -0.01 CNY | -108.0% |
| 2019 Q1 | 0.02 CNY | -77.53% |
| 2019 Q2 | 0.09 CNY | 441.62% |
| 2018 Q1 | 0.03 CNY | -68.14% |
| 2018 Q3 | 0.07 CNY | -54.38% |
| 2018 Q4 | 0.08 CNY | 5.48% |
| 2018 FY | - CNY | -22.22% |
| 2018 Q2 | 0.16 CNY | 403.14% |
| 2017 Q4 | 0.10 CNY | 22.0% |
| 2017 FY | - CNY | -2.17% |
| 2017 Q1 | 0.01 CNY | -91.5% |
| 2017 Q3 | 0.08 CNY | -65.92% |
| 2017 Q2 | 0.24 CNY | 2252.94% |
| 2016 Q4 | 0.12 CNY | 20.0% |
| 2016 Q3 | 0.10 CNY | 0.0% |
| 2016 FY | - CNY | -8.0% |
| 2015 FY | - CNY | 108.33% |
| 2014 FY | - CNY | -38.46% |
| 2013 FY | - CNY | 0.0% |